Redox control of microglial function: Molecular mechanisms and functional significance

Antioxidants and Redox Signaling

Volumn 21, Issue 12, 2014, Pages 1766-1801

  Rojo, Ana I ^a   McBean, Gethin ^b   Cindric, Marina ^c   Egea, Javier ^d   López, Manuela G ^d   Rada, Patricia ^a   Zarkovic, Neven ^e   Cuadrado, Antonio ^f  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d INSTITUTO TEÓFILO HERNANDO   (Spain)

^e RUDER BO KOVI INSTITUTE   (Croatia)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROSTANE DERIVATIVE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MALONALDEHYDE; NEUROPROSTANE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPPRESSOR OF CYTOKINE SIGNALING; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR NRF2; PROTEIN; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; EPIGENETICS; GLUTATHIONE METABOLISM; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE; LIPID PEROXIDATION; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHENOTYPE; REVIEW; ANIMAL; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; GLUTATHIONE; HUMANS; INFLAMMATION; MICROGLIA; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PROTEINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS;

EID: 84905837648     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5745     Document Type: Review

References (377)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, and Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25, 2010.
2. Abbott NJ, Ronnback L, and Hansson E. Astrocyteendothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53, 2006.
3. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, and Sorokin LM. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203: 1007-1019, 2006.
4. Ajami B, Bennett JL, Krieger C, Tetzlaff W, and Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10: 1538-1543, 2007.
5. Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, and Schmidt HH. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69: 2327-2343, 2012.
6. Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y, Wada T, and Handa H. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 36: 4327-4336, 2008.
7. Apopa PL, He X, and Ma Q. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J Biochem Mol Toxicol 22: 63-76, 2008.
8. Arnér ES. Focus on mammalian thioredoxin reductases - importante selenoproteins with versatile functions. Biochim Biophys Acta 1790: 495-526, 2009.
9. Avdic S, Cao JZ, McSharry BP, Clancy LE, Brown R, Steain M, Gottlieb DJ, Abendroth A, and Slobedman B. Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J Virol 87: 10273-10282, 2013.
10. Aybek H, Ercan F, Aslan D, and Sahiner T. Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clin Biochem 40: 172-176, 2007.
11. Baek KJ, Thiel BA, Lucas S, and Stuehr DJ. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem 268: 21120-21129, 1993.
12. Baker BJ, Akhtar LN, and Benveniste EN. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30: 392-400, 2009.
13. Bal-Price A, Matthias A, and Brown GC. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem 80: 73-80, 2002.
14. Barger SW and Basile AS. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 76: 846-854, 2001.
15. Barger SW, Goodwin ME, Porter MM, and Beggs ML. Glutamate release from activated microglia requires oxidative burst and lipid peroxidation. J Neurochem 101: 1205-1213, 2007.
16. Barker CF and Billingham RE. Immunologically privileged sites. Adv Immunol 25: 1-54, 1977.
17. Barone E, Di Domenico F, Cenini G, Sultana R, Coccia R, Preziosi P, Perluigi M, Mancuso C, and Butterfield DA. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. J Alzheimers Dis 25: 623-633, 2011.
18. Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M, and Butterfield DA. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52: 2292-2301, 2012.
19. Bassi MT, Gasol E, Manzoni M, Pineda M, Riboni M, Martin R, Zorzano A, Borsani G, and Palacin M. Identification and characterisation of human xCT that coexpresses, with 4F2 heavy chain, the amino acid transport activity system xc. Pflugers Arch 442: 286-296, 2001.
20. Bazan NG and Flower RJ. Medicine: lipid signals in pain control. Nature 420: 135-138, 2002.
21. Beckman JS and Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21: 330-334, 1993.
22. Bechmann I, Galea I, and Perry VH. What is the blood-brain barrier (not)? Trends Immunol 28: 5-11, 2007.
23. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
24. Beloosesky Y, Salman H, Bergman M, Bessler H, and Djaldetti M. Cytokine levels and phagocytic activity in patients with Alzheimer's disease. Gerontology 48: 128-132, 2002.
25. Berry CB, Hayes D, Murphy A, Wießner M, Rauen T, and McBean GJ. Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid. Brain Res 1037: 123-133, 2005.
26. Biaglow JE and Miller RA. The thioredoxin reductase/thioredoxin system. Novel redox targets for cancer therapy. Cancer Biol Ther 4: 6-13, 2005.
27. Biswas SK and Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896, 2010.
28. Block ML and Hong JS. Microglia and inflammationmediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76: 77-98, 2005.
29. Blouin E, Halbwachs-Mecarelli L, and Rieu P. Redox regulation of beta2-integrin CD11b/CD18 activation. Eur J Immunol 29: 3419-3431, 1999.
30. Boveris A and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134: 707-716, 1973.
31. Brown GC and Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994.
32. Brown GC and Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41: 242-247, 2010.
33. Butterfield DA, Reed T, and Sultana R. Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radic Res 45: 59-72, 2011.
34. Caito S, Yu Y, and Aschner M. Differential response to acrylonitrile toxicity in rat primary astrocytes and microglia. Neurotoxicology 37: 93-99, 2013.
35. Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, and Calabrese EJ. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med 32: 279-304, 2011.
36. Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, and Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 13: 1763-1811, 2010.
37. Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, and Calabrese EJ. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 1822: 753-783, 2012.
38. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, and Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8: 766-775, 2007.
39. Calingasan NY, Uchida K, and Gibson GE. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72: 751-756, 1999.
40. Cand F and Verdetti J. Superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation in the major organs of the aging rats. Free Radic Biol Med 7: 59-63, 1989.
41. Castellani RJ, Perry G, Siedlak SL, Nunomura A, Shimohama S, Zhang J, Montine T, Sayre LM, and Smith MA. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett 319: 25-28, 2002.
42. Chan AC, Tran K, Raynor T, Ganz PR, and Chow CK. Regeneration of vitamin E in human platelets. J Biol Chem 266: 17290-17295, 1991.
43. Chatterjee S, Noack H, Possel H, Keilhoff G, and Wolf G. Glutathione levels in primary glial cultures: monochlorobimane provides exidence of cell type-specific distribution. Glia 27: 152-161, 1999.
44. Chatterjee S, Noack H, Possel H, and Wolf G. Induction of nitric oxide synthesis lowers intracellular glutathione in microglia of primary microglial cultures. Glia 29: 98-101, 2000.
45. Cho HY, Reddy SP, Yamamoto M, and Kleeberger SR. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18: 1258-1260, 2004.
46. Cho N, Choi JH, Yang H, Jeong EJ, Lee KY, Kim YC, and Sung SH. Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines. Food Chem Toxicol 50: 1940-1945, 2012.
47. Choi SH, Aid S, and Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 30: 174-181, 2009.
48. Choi SH, Aid S, Kim HW, Jackson SH, and Bosetti F. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J Neurochem 120: 292-301, 2012.
49. Choi SH, Lee DY, Kim SU, and Jin BK. Thrombininduced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 25: 4082-4090, 2005.
50. Chu F, Ward NE, and O'Brian CA. Potent activation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor, cysteine. Carcinogenesis 22: 1221-1229, 2001.
51. Chowdhry S, Zhang Y, McMahon M, Sutherland C, Cuadrado A, and Hayes JD. Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32: 3765-3781, 2013.
52. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, and Vitek MP. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3: 27, 2006.
53. Cordle A and Landreth G. 3-Hydroxy-3-methylglutarylcoenzyme A reductase inhibitors attenuate beta-amyloidinduced microglial inflammatory responses. J Neurosci 25: 299-307, 2005.
54. Cornelius C, Perrotta R, Graziano A, Calabrese EJ, and Calabrese V. Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: Mitochondria as a "chi". Immun Ageing 10: 15, 2013.
55. Correa F, Mallard C, Nilsson M, and Sandberg M. Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3beta. Neurobiol Dis 44: 142-151, 2011.
56. Costello DA, Lyons A, Denieffe S, Browne TC, Cox FF, and Lynch MA. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation. J Biol Chem 286: 34722-34732, 2011.
57. Cullinan SB, Gordan JD, Jin J, Harper JW, and Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24: 8477-8486, 2004.
58. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, and Diehl JA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 23: 7198-7209, 2003.
59. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, and Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci 34: 85-96, 2009.
60. Dang TN, Arseneault M, Murthy V, and Ramassamy C. Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr Mol Pharmacol 3: 66-78, 2010.
61. Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, Deerinck TJ, Smirnoff DS, Bedard C, Hakozaki H, Gonias Murray S, Ling JB, Lassmann H, Degen JL, Ellisman MH, and Akassoglou K. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 3: 1227, 2012.
62. Davenport CM, Sevastou IG, Hooper C, and Pocock JM. Inhibiting p53 pathways in microglia attenuates microglialevoked neurotoxicity following exposure to Alzheimer peptides. J Neurochem 112: 552-563, 2010.
63. Davoust N, Vuaillat C, Androdias G, and Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol 29: 227-234, 2008.
64. de Boer AG and Gaillard PJ. Blood-brain barrier dysfunction and recovery. J Neural Transm 113: 455-462, 2006.
65. De Caterina R and Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol 206: 103-116, 2005.
66. DeChatelet LR, McPhail LC, Mullikin D, and McCall CE. An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest 55: 714-721, 1975.
67. del Rio-Hortega P. El "tercer elemento" de los centros nerviosos. Bol Soc Esp Biol 9: 69-120, 1919.
68. del Rio Hortega, P. Microglia. In: Cytology and Cellular Pathology of the Nervous System, edited by Penfield W, vol. 2. New York: PB Hoeber, 1032, pp. 481-534
69. Del Rio D, Stewart AJ, and Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15: 316-328, 2005.
70. Delibas N, Ozcankaya R, and Altuntas I. Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem 35: 137-141, 2002.
71. Denieffe S, Kelly RJ, McDonald C, Lyons A, and Lynch MA. Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells. Brain Behav Immun 34: 86-97, 2013.
72. Desai BS, Monahan AJ, Carvey PM, and Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant 16: 285-299, 2007.
73. Diaz-Meco MT, Berra E, Municio MM, Sanz L, Lozano J, Dominguez I, Diaz-Golpe V, Lain de Lera MT, Alcami J, Paya CV, et al. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Mol Cell Biol 13: 4770-4775, 1993.
74. Dib M, Garrel C, Favier A, Robin V, and Desnuelle C. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? J Neurol 249: 367-374, 2002.
75. Dopp JM, Sarafian TA, Spinella FM, Kahn MA, Shau H, and de Vellis J. Expression of the p75 TNF receptor is linked to TNF-induced NFKappaB translocation and oxyradical neutralization in glial cells. Neurochem Res 27: 1535-1542, 2002.
76. Doyle KP, Simon RP, and Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 55: 310-318, 2008.
77. 2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J Biol Chem 285: 27850-27858, 2010.
78. Egwuagu CE and Larkin III J. Therapeutic targeting of STAT pathways in CNS autoimmune diseases. JAKSTAT 2: e24134, 2013.
79. Engelhardt B. Regulation of immune cell entry into the central nervous system. Results Probl Cell Differ 43: 259-280, 2006.
80. Engelhardt B. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci 274: 23-26, 2008.
81. Engelhardt B and Coisne C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 8: 4, 2011.
82. Esterbauer H, Schaur RJ, and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
83. Eugenin EA, King JE, Hazleton JE, Major EO, Bennett MV, Zukin RS, and Berman JW. Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity. Neurotox Res 19: 138-148, 2011.
84. Eyo UB and Wu LJ. Bidirectional microglia-neuron communication in the healthy brain. Neural Plast 2013: 456857, 2013.
85. Farooqui AA, Horrocks LA, and Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem 101: 577-599, 2007.
86. Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, and Lassmann H. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135: 886-899, 2012.
87. Furukawa M and Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 25: 162-171, 2005.
88. Gehrmann J, Matsumoto Y, and Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 20: 269-287, 1995.
89. Ghosh A and Pahan K. Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders. J Biol Chem 287: 27189-27203, 2012.
90. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, and Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845, 2010.
91. Gloire G and Piette J. Redox regulation of nuclear posttranslational modifications during NF-kappaB activation. Antioxid Redox Signal 11: 2209-2222, 2009.
92. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, and Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11: 328-334, 2005.
93. Gueraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, Jouanin I, Siems W, and Uchida K. Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44: 1098-1124, 2010.
94. Hägglund P, Bunkenborg J, Maeda K, and Svensson B. Identification of thioredoxin disulfide targets using a quantitative proteomics approach based on isotope-coded affinity tags. J Proteome Res 7: 5270-5276, 2008.
95. Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, and Lassmann H. Oxidative damage in multiple sclerosis lesions. Brain 134: 1914-1924, 2011.
96. Hall ED, Detloff MR, Johnson K, and Kupina NC. Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma 21: 9-20, 2004.
97. Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, and Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem 101: 566-576, 2007.
98. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schoneich C, and Engelhardt JF. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118: 659-670, 2008.
99. Harrigan TJ, Abdullaev IF, Jourd'heuil D, and Mongin AA. Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases. J Neurochem 106: 2449-2462, 2008.
100. Hernandes MS, Santos GD, Cafe-Mendes CC, Lima LS, Scavone C, Munhoz CD, and Britto LR. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration. PLoS One 8: e75532, 2013.
101. Hess DC, Abe T, Hill WD, Studdard AM, Carothers J, Masuya M, Fleming PA, Drake CJ, and Ogawa M. Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol 186: 134-144, 2004.
102. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, and Markey SP. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320 (Pt 2): 595-597, 1996.
103. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
104. Hirrlinger J, Gutterer JM, Kussmaul L, Hamprecht B, and Dringen R. Microglial cells in culture express a prominent glutathione system for defense against reactive oxygen species. Dev Neuroscience 22: 384-392, 2000.
105. Hoetzenecker W, Echtenacher B, Guenova E, Hoetzenecker K, Woelbing F, Bruck J, Teske A, Valtcheva N, Fuchs K, Kneilling M, Park JH, Kim KH, Kim KW, Hoffmann P, Krenn C, Hai T, Ghoreschi K, Biedermann T, and Rocken M. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 18: 128-134, 2012.
106. Hollensworth SB, Shen C, Sim JE, Spitz DR, Wilson GL, and LeDoux SP. Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic Biol Med 15: 1161-1174, 2000.
107. Huang HC, Nguyen T, and Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277: 42769-42774, 2002.
108. Huang Z, Li J, Zhang S, and Zhang X. Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell. Toxicol Lett 187: 69-76, 2009.
109. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, and Kuhlmann CR. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24: 1023-1034, 2010.
110. Iantomasi T, Favilli F, Marraccini P, Stio M, Treves C, and Quattrone A. Age and GSH metabolism in rat cerebral cortex, as related to oxidative and energy parameters. Mech Ageing Dev 70: 65-82, 1993.
111. Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, de Ceballos ML, and Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181: 680-689, 2008.
112. Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, Yamamoto M, and Sekizawa K. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol 175: 6968-6975, 2005.
113. Jain AK and Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282: 16502-16510, 2007.
114. Jamaluddin M, Wang S, Boldogh I, Tian B, and Brasier AR. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19: 1419-1433, 2007.
115. Jayadev S, Yun B, Nguyen H, Yokoo H, Morrison RS, and Garden GA. The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes. J Neuroimmune Pharmacol 2: 359-370, 2007.
116. Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernandez-Ruiz J, and Cuadrado A. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal 14: 2347-2360, 2011.
117. 2 derived from NADPH oxidase: a cell culture study. J Neuroinflammation 3: 24, 2006.
118. Kacimi R, Giffard RG, and Yenari MA. Endotoxinactivated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways. J Inflamm (Lond) 8: 7, 2011.
119. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, and Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38: 3000-3006, 2007.
120. 2 +/calmodulin-dependent protein kinase 1 by S-glutathionylation of the active site cysteine residue. FEBS Lett 584: 2478-2484, 2010.
121. Kang CH, Jayasooriya RG, Dilshara MG, Choi YH, Jeong YK, Kim ND, and Kim GY. Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-kappaB activation and ERK phosphorylation. Food Chem Toxicol 50: 4270-4276, 2012.
122. Kato T, Jr., Delhase M, Hoffmann A, and Karin M. CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol Cell 12: 829-839, 2003.
123. Kelleher ZT, Matsumoto A, Stamler JS, and Marshall HE. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J Biol Chem 282: 30667-30672, 2007.
124. Keum YS, Owuor ED, Kim BR, Hu R, and Kong AN. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm Res 20: 1351-1356, 2003.
125. Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, Singh I, and Singh AK. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76: 519-527, 2004.
126. c - regulated microglia and macrophage glutamate excitotoxicity in vivo. Exp Neurol 233: 333-341, 2012.
127. Kim CY, Lee C, Park GH, and Jang JH. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloidinduced oxidative and nitrosative cell death via augmentation of antioxidant defence capacity. Arch Pharm Res 32: 869-881, 2009.
128. Kim H, Parka JH, Kim K. Lipid-like components released from degenerating dopaminergic neurons trigger the dynamic migration of microglia. Biochem Biophys Res Commun 426: 18-25, 2012.
129. Kitamura Y, Kakimura J, Koike H, Umeki M, Gebicke-Haerter PJ, Nomura Y, and Taniguchi T. Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. Eur J Pharmacol 411: 223-230, 2001.
130. Klatt P, Molina EP, De Lacoba MG, Padilla CA, Martinez-Galesteo E, Barcena JA, and Lamas S. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J 13: 1481-1490, 1999.
131. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, and Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24: 7130-7139, 2004.
132. Kobayashi M, Li L, Iwamoto N, Nakajima-Takagi Y, Kaneko H, Nakayama Y, Eguchi M, Wada Y, Kumagai Y, and Yamamoto M. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 29: 493-502, 2009.
133. Koppal T, Petrova TV, and Van Eldik LJ. Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells. Brain Res 867: 115-121, 2000.
134. Koriyama Y, Nakayama Y, Matsugo S, and Kato S. Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline. Brain Res 1499: 145-157, 2013.
135. Krizbai IA, Bauer H, Bresgen N, Eckl PM, Farkas A, Szatmari E, Traweger A, Wejksza K, and Bauer HC. Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell Mol Neurobiol 25: 129-139, 2005.
136. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, and Kensler TW. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23: 8786-8794, 2003.
137. Lallena MJ, Diaz-Meco MT, Bren G, Paya CV, and Moscat J. Activation of IkappaB kinase beta by protein kinase C isoforms. Mol Cell Biol 19: 2180-2188, 1999.
138. Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, and Boczkowski J. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19: 1890-1892, 2005.
139. Larochelle C, Alvarez JI, and Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 585: 3770-3780, 2011.
140. Laschinger M, Vajkoczy P, and Engelhardt B. Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur J Immunol 32: 3598-3606, 2002.
141. Lassmann H, Schmied M, Vass K, and Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 7: 19-24, 1993.
142. Lastres-Becker I, Innamorato NG, Jaworski T, Rabano A, Kugler S, Van Leuven F, and Cuadrado A. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain 137: 78-91, 2014.
143. Lawson LJ, Perry VH, Dri P, and Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151-170, 1990.
144. Lee H, Lee S, Cho IH, and Lee SJ. Toll-like receptors: sensor molecules for detecting damage to the nervous system. Curr Protein Pept Sci 14: 33-42, 2013.
145. Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, and McGeer PL. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degeneration in neurological diseases. FASEB J 24: 2533-2545, 2010.
146. Lee M, Tazzari V, Giustarini D, Rossi R, Sparatore A, Del Soldato P, McGeer E, and McGeer PL. Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson's disease. J Biol Chem 285: 17318-17328, 2010.
147. Lee S, Lee J, Kim S, Park JY, Lee WH, Mori K, Kim SH, Kim IK, and Suk K. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol 179: 3231-3241, 2007.
148. Lee S, Park JY, Lee WH, Kim H, Park HC, Mori K, and Suk K. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 29: 234-249, 2009.
149. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF, Camacho F, Diaz-Meco MT, Rennert PD, and Moscat J. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell 8: 771-780, 2001.
150. Leonardo CC and Dore S. Dietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins. Nutr Neurosci 14: 226-236, 2011.
151. Li B, Bedard K, Sorce S, Hinz B, Dubois-Dauphin M, and Krause KH. NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive IL-6 expression. J Innate Immun 1: 570-581, 2009.
152. Li N, Alam J, Venkatesan MI, Eiguren-Fernandez A, Schmitz D, Di Stefano E, Slaughter N, Killeen E, Wang X, Huang A, Wang M, Miguel AH, Cho A, Sioutas C, and Nel AE. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol 173: 3467-3481, 2004.
153. Li W and Kong AN. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog 48: 91-104, 2009.
154. Liao B, Zhao W, Beers DR, Henkel JS, and Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol 237: 147-152, 2012.
155. Lindenau J, Noack H, Asayama K, and Wolf G. Enhanced cellular glutathione peroxidase imunoreactivity in activated astrocytes and in microglia during excitotoxininduced neurodegeneration. Glia 24: 252-256, 1998.
156. Lischper M, Beuck S, Thanabalasundaram G, Pieper C, and Galla HJ. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res 1326: 114-127, 2010.
157. Liu R and Choi J. Age-associated decline in gammaglutamylcysteine synthetase gene expression in rats. Free Radic Biol Med 28: 566-574, 2000.
158. Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood JS, Forman HJ, Thannickal VJ, and Postlethwait EM. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem 285: 16239-16247, 2010.
159. Liu X, Lovell MA, and Lynn BC. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Anal Chem 77: 5982-5989, 2005.
160. Liu Y, Teige I, Birnir B, and Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 12: 518-525, 2006.
161. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, De-Marco KM, Nametz N, and Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30: 1625-1636, 2010.
162. Lovell MA, Xie C, and Markesbery WR. Acrolein is increased in Alzheimer's disease brain and is toxic to pri-mary hippocampal cultures. Neurobiol Aging 22: 187-194, 2001.
163. Lu DY, Huang BR, Yeh WL, Lin HY, Huang SS, Liu YS, and Kuo YH. Anti-neuroinflammatory effect of a novel caffeamide derivative, KS370G, in microglial cells. Mol Neurobiol 48: 863-874, 2013.
164. Lu J and Holmgren A. Thioredoxin system in cell death progression. Antioxid Redox Signal 17: 1738-1747, 2012.
165. Lyons A, Downer EJ, Crotty S, Nolan YM, Mills KH, and Lynch MA. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci 27: 8309-8313, 2007.
166. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, Wasserman WW, and Biswal S. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38: 5718-5734, 2010.
167. Mancuso C and Barone E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr Drug Metab 10: 579-594, 2009.
168. Mancuso C, Barone E, Guido P, Miceli F, Di Domenico F, Perluigi M, Santangelo R, and Preziosi P. Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro. Neurosci Lett 518: 101-105, 2012.
169. Mancuso C, Capone C, Ranieri SC, Fusco S, Calabrese V, Eboli ML, Preziosi P, Galeotti T, and Pani G. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res 86: 2235-2249, 2008.
170. Mancuso C, Navarra P, and Preziosi P. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. J Neurochem 113: 563-575, 2010.
171. Mancuso C, Pistritto G, Tringali G, Grossman AB, Preziosi P, and Navarra P. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes. Brain Res Mol Brain Res 45: 294-300, 1997.
172. Mancuso C, Preziosi P, Grossman AB, and Navarra P. The role of carbon monoxide in the regulation of neuroendocrine function. Neuroimmunomodulation 4: 225-229, 1997.
173. Mancuso C, Ragazzoni E, Tringali G, Liberale I, Preziosi P, Grossman A, and Navarra P. Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat. J Neuroimmunol 99: 189-194, 1999.
174. Mander P and Brown GC. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J Neuroinflammation 2: 20, 2005.
175. Mantovani A, Sozzani S, Locati M, Allavena P, and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002.
176. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, and Bazan NG. Novel docosanoids inhibit brain ischemiareperfusion-mediated leukocyte infiltration and proinflammatory gene expression. J Biol Chem 278: 43807-43817, 2003.
177. Marden JJ, Harraz MM, Williams AJ, Nelson K, Luo M, Paulson H, and Engelhardt JF. Redox modifier genes in amyotrophic lateral sclerosis in mice. J Clin Invest 117: 2913-2919, 2007.
178. Marik C, Felts PA, Bauer J, Lassmann H, and Smith KJ. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130: 2800-2815, 2007.
179. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, and Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 41: 535-547, 2004.
180. Markesbery WR, Kryscio RJ, Lovell MA, and Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58: 730-735, 2005.
181. Markesbery WR and Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19: 33-36, 1998.
182. Martinez FO, Sica A, Mantovani A, and Locati M. Macrophage activation and polarization. Front Biosci 13: 453-461, 2008.
183. Mattson MP. NF-kappaB in the survival and plasticity of neurons. Neurochem Res 30: 883-893, 2005.
184. McBean GJ. Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci 23: 299-302, 2002.
185. McCaffrey G, Willis CL, Staatz WD, Nametz N, Quigley CA, Hom S, Lochhead JJ, and Davis TP. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem 110: 58-71, 2009.
186. McMahon M, Thomas N, Itoh K, Yamamoto M, and Hayes JD. Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279: 31556-31567, 2004.
187. McNeill E and Channon KM. The role of tetrahydrobiopterin in inflammation and cardiovascular disease. Thromb Haemost 108: 832-839, 2012.
188. Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29: 58-69, 1948.
189. Meja KK, Rajendrasozhan S, Adenuga D, Biswas SK, Sundar IK, Spooner G, Marwick JA, Chakravarty P, Fletcher D, Whittaker P, Megson IL, Kirkham PA, and Rahman I. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 39: 312-323, 2008.
190. Mercado N, Thimmulappa R, Thomas CM, Fenwick PS, Chana KK, Donnelly LE, Biswal S, Ito K, and Barnes PJ. Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun 406: 292-298, 2011.
191. Mertsch K, Blasig I, and Grune T. 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier. Neurosci Lett 314: 135-138, 2001.
192. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Bruck W, Priller J, and Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2 + monocytes only under defined host conditions. Nat Neurosci 10: 1544-1553, 2007.
193. Min KJ, Pyo HK, Yang MS, Ji KA, Jou I, and Joe EH. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia 48: 197-206, 2004.
194. Min KJ, Yang MS, Kim SU, Jou I, and Joe EH. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J Neurosci 26: 1880-1887, 2006.
195. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, and Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79, 2012.
196. Miziu T, Kinouchi H, and Chan PH. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischaemic injury in rats. Am J Physiol 262: H313-H317, 1992.
197. Moi P, Chan K, Asunis I, Cao A, and Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91: 9926-9930, 1994.
198. Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ, 2nd, Morrow JD, and Montine TJ. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids 128: 117-124, 2004.
199. Morsali D, Bechtold D, Lee W, Chauhdry S, Palchaudhuri U, Hassoon P, Snell DM, Malpass K, Piers T, Pocock J, Roach A, and Smith KJ. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Brain 136: 1067-1082, 2013.
200. Moss DW and Bates TE. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci 13: 529-538, 2001.
201. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, and Neuwelt EA. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab 33: 13-21, 2013.
202. Murphy JB and Sturm E. Conditions determining the transplantability of tissues in the brain. J Exp Med 38: 183-197, 1923.
203. Nag S and Begley DJ. Blood-brain barrier, exchange of metabolites and gases. In: Pathology and Genetics. Cerebrovascular Diseases. edited by Kalimo H. Basel, Switzerland: ISN Neuropath. Press, 2005, pp. 22-29.
204. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Drain PF, Wang X, Sasidhar M, Nabel EG, Takahashi T, Lukacs NW, Ryter SW, Morita K, and Choi AM. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203: 2377-2389, 2006.
205. Nalvarte I, Damdimopolous AE, and Spyrou G. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Radic Biol Med 36: 1270-1278, 2004.
206. Narasimhan M, Patel D, Vedpathak D, Rathinam M, Henderson G, and Mahimainathan L. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One 7: e51111, 2012.
207. Nayernia Z, Jaquet V, and Krause K.-H. New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal 20: 2815-2837, 2014.
208. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RC, Wiswedel I, Zarkovic K, and Zarkovic N. Pathological aspects of lipid peroxidation. Free Radic Res 44: 1125-1171, 2010.
209. Nemoto S, DiDonato JA, and Lin A. Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase. Mol Cell Biol 18: 7336-7343, 1998.
210. Newcombe J, Li H, and Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20: 152-162, 1994.
211. Nimmerjahn A, Kirchhoff F, and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318, 2005.
212. Nisimoto Y, Jackson HM, Ogawa H, Kawahara T, and Lambeth JD. Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain. Biochemistry 49: 2433-2442, 2010.
213. Njie EG, Boelen E, Stassen FR, Steinbusch HW, Borchelt DR, and Streit WJ. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging 33: 195 e1-e12, 2012.
214. Noack H, Possel H, Chatterjee S, Keilhoff G, and Wolf G. Nitrosative stress in primary glial cultures after induction of the inducible isoform of nitric oxide synthase (i-NOS). Toxicology 148: 133-142, 2000.
215. Norden DM and Godbout JP. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39: 19-34, 2013.
216. Nowak DE, Tian B, Jamaluddin M, Boldogh I, Vergara LA, Choudhary S, and Brasier AR. RelA Ser276 phosphorylation is required for activation of a subset of NFkappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol Cell Biol 28: 3623-3638, 2008.
217. Obin M, Shang F, Gong X, Handelman G, Blumberg J, and Taylor A. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J 12: 561-569, 1998.
218. Oh J, Hur MW, and Lee CE. SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis. Oncogene 28: 3145-3156, 2009.
219. Owens T, Bechmann I, and Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 67: 1113-1121, 2008.
220. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, and Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469: 6-10, 2010.
221. Pahan K, Sheikh FG, Namboodiri AM, and Singh I. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med 24: 39-48, 1998.
222. Pais TF, Szego EM, Marques O, Miller-Fleming L, Antas P, Guerreiro P, de Oliveira RM, Kasapoglu B, and Outeiro TF. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32: 2603-2616, 2013.
223. Pampliega O, Domercq M, Soria FN, Villoslada P, Rodríguez-Antigüedad A, and Matute C. Increased expression of cystine/glutamate antiporter in multiple sclerosis. J Neuroinflammation 8: 63-75, 2011.
224. Pamplona R. Advanced lipoxidation end-products. Chem Biol Interact 192: 14-20, 2011.
225. Pannu R, Won JS, Khan M, Singh AK, and Singh I. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J Neurosci 24: 5942-5954, 2004.
226. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, and Gross CT. Synaptic pruning by microglia is necessary for normal brain development. Science 333: 1456-1458, 2011.
227. Park HS, Mo JS, and Choi EJ. Nitric oxide inhibits an interaction between JNK1 and c-Jun through nitrosylation. Biochem Biophys Res Commun 351: 281-286, 2006.
228. Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA, and Iadecola C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25: 1769-1777, 2005.
229. Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, Younkin L, Younkin S, Carlson G, McEwen BS, and Iadecola C. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci U S A 105: 1347-1352, 2008.
230. Parsons ZD and Gates KS. Thiol-dependent recovery of catalytic activity from oxidized protein tyrosine phosphatases. Biochemistry 37: 6412-6423, 2013.
231. Pawate S, Shen Q, Fan F, and Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77: 540-551, 2004.
232. Pena OM, Pistolic J, Raj D, Fjell CD, and Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 186: 7243-7254, 2011.
233. Perry VH, Nicoll JA, and Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 6: 193-201, 2010.
234. Persson M and Rönnbäck L. Microglial self-defence mediated through GLT-1 and gluathione. Amino Acids 42: 207-219, 2012.
235. Persson M, Sandberg M, Hansson E, and Rönnbäck L. Microglial glutamate uptake is coupled to glutathione synthesis and glutamate release. Eur J Neurosci 24: 1063-1070, 2006.
236. Petersen DR and Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37: 937-945, 2004.
237. Peterson LJ and Flood PM. Oxidative stress and microglial cells in Parkinson's disease. Mediators Inflamm 2012: 401264, 2012.
238. Petry A, Weitnauer M, and Gorlach A. Receptor activation of NADPH oxidases. Antioxid Redox Signal 13: 467-487, 2010.
239. Pettit LK, Varsanyi C, Tadros J, and Vassiliou E. Modulating the inflammatory properties of activated microglia with docosahexaenoic acid and aspirin. Lipids Health Dis 12: 16, 2013.
240. c - in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152: 3578-3585, 1994.
241. Piani D, Spranger M, Frei K, Schaffner A, and Fontana A. Macrophage-induced cytotoxicity of N-methyl-d-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 22: 2429-2436, 1992.
242. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, and Lamas S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redoxinduced inhibition of DNA binding. Biochemistry 40: 14134-14142, 2001.
243. Pistritto G, Mancuso C, Tringali G, Perretti M, Preziosi P, and Navarra P. The relative contribution of constitutive and inducible cyclooxygenase activity to lipopolysaccharide-induced prostaglandin production by primary cultures of rat hypothalamic astrocytes. Neurosci Lett 246: 45-48, 1998.
244. Ponomarev ED, Maresz K, Tan Y, and Dittel BN. CNSderived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721, 2007.
245. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, Mantovani A, and Sica A. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106: 14978-14983, 2009.
246. Powell CS and Jackson RM. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxiareoxygenation: modulation of enzyme activities by MnSOD. Am J Physiol Lung Cell Mol Physiol 285: L189-L198, 2003.
247. Power JH and Blumbergs PC. Cellular glutathione peroxidase in human brain: celluar distribution and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol 117: 63-73, 2009.
248. Puntener U, Booth SG, Perry VH, and Teeling JL. Longterm impact of systemic bacterial infection on the cerebral vasculature and microglia. J Neuroinflammation 9: 146, 2012.
249. Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, and Benveniste EN. SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J Immunol 189: 3439-3448, 2012.
250. Qin L and Crews FT. NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J Neuroinflammation 9: 5, 2012.
251. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, and Hong JS. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279: 1415-1421, 2004.
252. Rada P, Rojo AI, Chowdhry S, McMahon M, Hayes JD, and Cuadrado A. SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol 31: 1121-1133, 2011.
253. Rada P, Rojo AI, Evrard-Todeschi N, Innamorato NG, Cotte A, Jaworski T, Tobon-Velasco JC, Devijver H, Garcia-Mayoral MF, Van Leuven F, Hayes JD, Bertho G, and Cuadrado A. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/beta-TrCP axis. Mol Cell Biol 32: 3486-3499, 2012.
254. Ralat LA, Ren M, Schilling AB, and Tang WJ. Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation. J Biol Chem 284: 34005-34018, 2009.
255. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, and Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114: 1248-1259, 2004.
256. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59, 2005.
257. Ravichandran V, Seres T, Moriguchi T, Thomas JA, and Johnston RBJ. S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem 269: 25010-25015, 1994.
258. Rebrin I and Sohal RS. Pro-oxidant shift in glutathione redox state during aging. Adv Drug Deliv Rev 60: 1545-1552, 2008.
259. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, and Butterfield DA. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30: 107-120, 2008.
260. Reed TT. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 51: 1302-1319, 2011.
261. Reynolds AD, Kadiu I, Garg SK, Glanzer JG, Nordgren T, Ciborowski P, Banerjee R, and Gendelman HE. Nitrated alpha-synuclein and microglial neuroregulatory activities. J Neuroimmune Pharmacol 3: 59-74, 2008.
262. Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M, and Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 58: 588-598, 2010.
263. Rojo AI, Sagarra MR, and Cuadrado A. GSK-3beta downregulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105: 192-202, 2008.
264. Rossi-George A, Guo CJ, Oakes BL, and Gow AJ. Copper modulates the phenotypic response of activated BV2 microglia through the release of nitric oxide. Nitric Oxide 27: 201-209, 2012.
265. Roy A, Jana A, Yatish K, Freidt MB, Fung YK, Martinson JA, and Pahan K. Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases. Free Radic Biol Med 45: 686-699, 2008.
266. Roychowdhury S, Wolf G, Keilhoff G, and Horn TF. Cytosolic and mitochondrial glutathione in microglial cells are differentially affected by oxidative/nitrosative stress. Nitric Oxide 8: 39-47, 2002.
267. Ruoppolo M, Freedman RB, Pucci P, and Marino G. Glutathione-dependent pathways of refolding of RNase T1 by oxidation and disulfide isomerization: catalysis by protein disulfide isomerase. Biochemistry 35: 13636-13646, 1996.
268. Rushmore TH, King RG, Paulson KE, and Pickett CB. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc Natl Acad Sci U S A 87: 3826-3830, 1990.
269. Saha RN and Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8: 929-947, 2006.
270. Salazar M, Rojo AI, Velasco D, de Sagarra RM, and Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281: 14841-14851, 2006.
271. Sanchez-Guajardo V, Barnum CJ, Tansey MG, and Romero-Ramos M. Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro 5: 113-139, 2013.
272. Sanson M, Distel E, and Fisher EA. HDL induces the expression of the M2 macrophage markers arginase 1 and fizz-1 in a STAT6-dependent process. PLoS One 8: e74676, 2013.
273. Sato H, Tamba M, Ishii T, and Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274: 11455-11458, 1999.
274. Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, and Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44: 192-201, 2011.
275. Scarpa S, Cavallaro RA, D'Anselmi F, and Fuso A. Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J Alzheimers Dis 9: 407-414, 2006.
276. Schilling T, Stock C, Schwab A, and Eder C. Functional importance of Ca2+ -activated K+ channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci 19: 1469-1474, 2004.
277. Schlag GŽK, Redl H, Žarković N, Waeg G. Brain damage secondary to hemorrhagic traumatic shock in baboons. 5th Wiggers Bernard Conference "Shock, sepsis, and organ failure - brain damage secondary to hemorrhagic - traumatic shock, sepsis, and traumatic brain injury". Schlag G, Redl H, Traber D (ur.). Heildelberg: Springer-Verlag, 1997, pp. 3-19.
278. Schlegelmilch T, Henke K, and Peri F. Microglia in the developing brain: from immunity to behaviour. Curr Opin Neurobiol 21: 5-10, 2011.
279. Scholz M, Cinatl J, Schadel-Hopfner M, and Windolf J. Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev 27: 401-416, 2007.
280. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, and de Vries HE. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21: 3666-3676, 2007.
281. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, and Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 2007.
282. Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, and O'Banion MK. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 27: 9301-9309, 2007.
283. Shamoto-Nagai M, Maruyama W, Hashizume Y, Yoshida M, Osawa T, Riederer P, and Naoi M. In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J Neural Transm 114: 1559-1567, 2007.
284. Sharma V, Mishra M, Ghosh S, Tewari R, Basu A, Seth P, and Sen E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull 73: 55-63, 2007.
285. Sheldon KE, Shandilya H, Kepka-Lenhart D, Poljakovic M, Ghosh A, and Morris SM, Jr. Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter. J Immunol 191: 2290-2298, 2013.
286. Shen G, Hebbar V, Nair S, Xu C, Li W, Lin W, Keum YS, Han J, Gallo MA, and Kong AN. Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J Biol Chem 279: 23052-23060, 2004.
287. Shibata N, Nagai R, Uchida K, Horiuchi S, Yamada S, Hirano A, Kawaguchi M, Yamamoto T, Sasaki S, and Kobayashi M. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 917: 97-104, 2001.
288. Sierra-Filardi E, Vega MA, Sanchez-Mateos P, Corbi AL, and Puig-Kroger A. Heme oxygenase-1 expression in MCSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215: 788-795, 2010.
289. Sierra A, Encinas JM, Deudero JJ, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, Tsirka SE, and Maletic-Savatic M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7: 483-495, 2010.
290. Smeyne M and Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med [Epub ahead of print]; DOI: 10.1016/j.freeradbiomed.2013.05.001.
291. Sorce S and Krause KH. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 11: 2481-2504, 2009.
292. Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, Borregaard N, Jones DP, Gewirtz AT, and Vijay-Kumar M. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxininduced sepsis. J Immunol 189: 1911-1919, 2012.
293. Stewart VC, Heslegrave AJ, Brown GC, Clark JB, and Heales SJ. Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor. Eur J Neurosci 15: 458-464, 2002.
294. Streit WJ. Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev 48: 234-239, 2005.
295. Streit WJ, Braak H, Xue QS, and Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118: 475-485, 2009.
296. Streit WJ, Sammons NW, Kuhns AJ, and Sparks DL. Dystrophic microglia in the aging human brain. Glia 45: 208-212, 2004.
297. Su ZY, Shu L, Khor TO, Lee JH, Fuentes F, and Kong AN. A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics. Top Curr Chem 329: 133-162, 2013.
298. Sun Z, Chin YE, and Zhang DD. Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol Cell Biol 29: 2658-2672, 2009.
299. Sun Z, Huang Z, and Zhang DD. Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 4: e6588, 2009.
300. Surai PF, Speake BK, Noble RC, and Sparks NH. Tissuespecific antioxidant profiles and susceptibility to lipid peroxidation of the newly hatched chick. Biol Trace Elem Res 68: 63-78, 1999.
301. Taguchi K, Fujikawa N, Komatsu M, Ishii T, Unno M, Akaike T, Motohashi H, and Yamamoto M. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci U S A 109: 13561-13566, 2012.
302. Taille C, El-Benna J, Lanone S, Boczkowski J, and Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280: 25350-25360, 2005.
303. Taille C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M, and Boczkowski J. Induction of heme oxygenase-1. inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 279: 28681-28688, 2004.
304. Takeshita Y and Ransohoff RM. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol Rev 248: 228-239, 2012.
305. Talalay P, Dinkova-Kostova AT, and Holtzclaw WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 43: 121-134, 2003.
306. Tchaikovskaya T, Fraifeld V, Urphanishvili T, Andorfer JH, Davies P, and Listowsky I. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mech Ageing Dev 126: 309-315, 2005.
307. Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, and Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116: 984-995, 2006.
308. Thimmulappa RK, Scollick C, Traore K, Yates M, Trush MA, Liby KT, Sporn MB, Yamamoto M, Kensler TW, and Biswal S. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDOImidazolide. Biochem Biophys Res Commun 351: 883-889, 2006.
309. Tian L, Kilgannon P, Yoshihara Y, Mori K, Gallatin WM, Carpen O, and Gahmberg CG. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. Eur J Immunol 30: 810-818, 2000.
310. Tichauer JE, Flores B, Soler B, Eugenin-von Bernhardi L, Ramirez G, and von Bernhardi R. Age-dependent changes on TGFbeta1 Smad3 pathway modify the pattern of microglial cell activation. Brain Behav Immun 37: 187-196, 2014.
311. Toledano MB, Ghosh D, Trinh F, and Leonard WJ. Nterminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol Cell Biol 13: 852-860, 1993.
312. Tomimoto H, Shibata M, Ihara M, Akiguchi I, Ohtani R, and Budka H. A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol 104: 601-607, 2002.
313. Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, and Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol 26: 2887-2900, 2006.
314. Tremblay ME, Lowery RL, and Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8: e1000527, 2010.
315. Trigona WL, Mullarky IK, Cao Y, and Sordillo LM. Thioredoxin reductase regulates the induction of haemoxygenase-1 expression in aortic endothelial cells. Biochem J 394: 207-216, 2006.
316. Tringali G, Mancuso C, Mirtella A, Pozzoli G, Parente L, Preziosi P, and Navarra P. Evidence for the neuronal origin of immunoreactive interleukin-1 beta released by rat hypothalamic explants. Neurosci Lett 219: 143-146, 1996.
317. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Tamaoka Y, Yodoi J, and Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274: 35809-35815, 1999.
318. Ulleveig S, Kim HS, and Asmis R. S-glutathionylation in monocyte and macrophage (dys)function. Int J Mol Sci 14: 15212-15232, 2013.
319. Ungvari Z, Tucsek Z, Sosnowska D, Toth P, Gautam T, Podlutsky A, Csiszar A, Losonczy G, Valcarcel-Ares MN, Sonntag WE, and Csiszar A. Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells. J Gerontol A Biol Sci Med Sci 68: 877-891, 2013.
320. Usatyuk PV, Parinandi NL, and Natarajan V. Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. J Biol Chem 281: 35554-35566, 2006.
321. Vajkoczy P, Laschinger M, and Engelhardt B. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest 108: 557-565, 2001.
322. Van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, and De Vries HE. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J 15: 1852-1854, 2001.
323. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, and Srivenugopal KS. Human p53 is inhibited by glutahionylation of cysteines present in the proximal DNAbinding domain during oxidative stress. Biochemistry 46: 7765-7780, 2007.
324. Venema RC, Ju H, Zou R, Ryan JW, and Venema VJ. Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem 272: 1276-1282, 1997.
325. Vos CM, Geurts JJ, Montagne L, van Haastert ES, Bo L, van der Valk P, Barkhof F, and de Vries HE. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis 20: 953-960, 2005.
326. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, and Sofroniew MV. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29: 11511-11522, 2009.
327. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, and Hanisch UK. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50: 235-246, 2005.
328. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, and Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29: 3974-3980, 2009.
329. Wang B, Navath RS, Romero R, Kannan S, and Kannan R. Anti-inflamatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Int J Pharm 377: 159-168, 2009.
330. Wang B, Zhu X, Kim Y, Li J, Huang S, Saleem S, Li RC, Xu Y, Dore S, and Cao W. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med 52: 928-936, 2012.
331. Wang H, Khor TO, Saw CL, Lin W, Wu T, Huang Y, and Kong AN. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Mol Pharm 7: 2185-2193, 2010.
332. Wang H, Liu H, and Liu RM. Gender difference in glutathione metabolism during aging in mice. Exp Gerontol 38: 507-517, 2003.
333. Wang P, Liu GH, Wu K, Qu J, Huang B, Zhang X, Zhou X, Gerace L, and Chen C. Repression of classical nuclear export by S-nitrosylation of CRM1. J Cell Sci 122: 3772-3779, 2009.
334. Wang X, Svedin P, Nie C, Lapatto R, Zhu C, Gustavsson M, Sandberg M, Karlsson JO, Romero R, Hagberg H, and Mallard C. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol 61: 263-271, 2007.
335. Weiss N, Miller F, Cazaubon S, and Couraud PO. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788: 842-857, 2009.
336. Wheeler D, Bandaru VV, Calabresi PA, Nath A, and Haughey NJ. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 131: 3092-3102, 2008.
337. Williams TI, Lynn BC, Markesbery WR, and Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 27: 1094-1099, 2006.
338. Winkler EA, Bell RD, and Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci 14: 1398-1405, 2011.
339. Wolburg H, Wolburg-Buchholz K, and Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol 109: 181-190, 2005.
340. Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E, Loser K, Beissert S, Georges-Labouesse E, and Sorokin LM. Endothelial basement membrane laminin alpha5 se-lectively inhibits T lymphocyte extravasation into the brain. Nat Med 15: 519-527, 2009.
341. Wu DC, Re DB, Nagai M, Ischiropoulos H, and Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci U S A 103: 12132-12137, 2006.
342. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, and Przedborski S. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 100: 6145-6150, 2003.
343. Wu SZ, Bodles AM, Porter MM, Griffin WS, Basile AS, and Barger SW. Induction of serine racemase expression and D-serine release from microglia by amyloid betapeptide. J Neuroinflammation 1: 2, 2004.
344. Xu C, Yuan X, Pan Z, Shen G, Kim JH, Yu S, Khor TO, Li W, Ma J, and Kong AN. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther 5: 1918-1926, 2006.
345. Yamamoto T, Kyo M, Kamiya T, Tanaka T, Engel JD, Motohashi H, and Yamamoto M. Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements. Genes Cells 11: 575-591, 2006.
346. Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, and Yamamoto M. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28: 2758-2770, 2008.
347. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, and Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291: L46-L57, 2006.
348. Yang SR, Valvo S, Yao H, Kode A, Rajendrasozhan S, Edirisinghe I, Caito S, Adenuga D, Henry R, Fromm G, Maggirwar S, Li JD, Bulger M, and Rahman I. IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol 38: 689-698, 2008.
349. Yang Y and Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42: 3323-3328, 2011.
350. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, and Yoshimura A. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 18: 1309-1320, 1999.
351. Yenari MA, Xu L, Tang XN, Qiao Y, and Giffard RG. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37: 1087-1093, 2006.
352. Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, Ullah F, Dyall SC, Malaspina A, Bendotti C, and Michael-Titus A. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One 8: e61626, 2013.
353. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, and Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A 93: 2696-2701, 1996.
354. Zarkovic K. 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24: 293-303, 2003.
355. Zarkovic KCM, Kolenc D, and Zarkovic N. 4-Hydroxynoneal as second messenger of free radicals in the blood-brain barrier. Conference Abstract: Pharmacology and Toxicology of the Blood-Brain Barrier: State of the Art, Needs for Future Research and Expected Benefits for the EU. 2010.
356. Zarkovic KZN, Schlag G, Redl H, and Waeg G. Histological aspects of sepsis induced brain changes in a baboon model. In: Shock, Sepsis and Organ Failure, 5th Wiggers Bernard Conference, edited by Schlag G, Redl H, and Traber DL. Heidelberg: Springer-Verlag, 1997, pp. 146-160.
357. Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24: 281-291, 2003.
358. Zarkovic N, Cipak A, Jaganjac M, Borovic S, and Zarkovic K. Pathophysiological relevance of aldehydic protein modifications. J Proteomics 92: 239-247, 2013.
359. Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, and Hlavka V. 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci 65: 1901-1904, 1999.
360. Zhang DD and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151, 2003.
361. Zhang DD, Lo SC, Cross JV, Templeton DJ, and Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 24: 10941-10953, 2004.
362. Zhang F, Qian L, Flood PM, Shi JS, Hong JS, and Gao HM. Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmacol Exp Ther 333: 822-833, 2010.
363. Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, and Wang Z. Neuroprotective effects of salidroside against betaamyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int 57: 547-555, 2010.
364. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhou Y, Hong JS, and Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19: 533-542, 2005.
365. Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Hong JS, and Liu B. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J 18: 589-591, 2004.
366. Zhang X, Guo L, Collage RD, Stripay JL, Tsung A, Lee JS, and Rosengart MR. Calcium/calmodulin-dependent protein kinase (CaMK) 1 alpha mediates the macrophage inflammatory response to sepsis. J Leukoc Biol 90: 249-261, 2011.
367. Zhang Z, Zhang ZY, Wu Y, and Schluesener HJ. Lesional accumulation of CD163 + macrophages/microglia in rat traumatic brain injury. Brain Res 1461: 102-110, 2012.
368. Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, Simpson EP, Yes AA, Xiao Q, and Appel SH. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 63: 964-977, 2004.
369. Zhong H, May MJ, Jimi E, and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002.
370. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, and Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424, 1997.
371. Zhong H, Voll RE, and Ghosh S. Phosphorylation of NFkappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671, 1998.
372. Zhou H, Lapointe BM, Clark SR, Zbytnuik L, and Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol 177: 8103-8110, 2006.
373. Zhou Y, Ling EA, and Dheen ST. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem 102: 667-678, 2007.
374. Zhu Y, Carvey PM, and Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res 1090: 35-44, 2006.
375. Zipper LM and Mulcahy RT. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J Biol Chem 277: 36544-36552, 2002.
376. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201, 2008.
377. Zmijewski JW, Banerjee S, and Abraham E. Sglutathionylation of the Rpn2 regulatory subunit inhibits 26S proteasomal function. J Biol Chem 284: 22213-22221, 2009.